Hims & Hers Health, Novo Nordisk end weight loss medication suit, enter collaboration
ABC News
Hims & Hers Health has agreed to stop selling compound versions of Novo Nordisk’s Wegovy and other weight-loss drugs, ending for now a patent lawsuit
Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have reached an agreement that will see Novo Nordisk’s branded weight loss medicines sold through the Hims platform.
Early last month Hims & Hers said that it was going to launch a cheaper, off-brand version of the weight-loss pill Wegovy, just weeks after drugmaker Novo Nordisk launched its highly anticipated reformulation of the blockbuster medication. At the time, Novo Nordisk vowed to sue Hims, calling the new product “an unapproved, inauthentic, and untested knockoff” of semaglutide, the chemical name for Wegovy.
But just two days later, Hims dropped its plan to offer the cheaper, off-brand version of Wegovy. That move came a day after the Food and Drug Administration threatened to restrict access to the ingredients needed to copy popular weight-loss medications.
The FDA permits specialty pharmacies and other companies to make compounded versions of brand name drugs when they are in short supply. And the booming demand for GLP-1 drugs in recent years prompted companies like Hims to jump into the multibillion-dollar market for the drugs, with many patients willing to pay cash.
In 2024, the FDA said that GLP-1 drugs were no longer in a shortage, which was expected to put an end to the compounding. But companies like Hims relied on an exception to keep selling their versions of the medications because the practice is still permitted when a prescription is customized for the patient.
A strong chemical smell has forced a temporary halt to flights at four major airports near Washington, D.C. The FAA says air traffic controllers cannot manage traffic safely during the incident
U.S. job openings rose to nearly 7 million in January, better than expected at a time when the American labor market has looked sluggish
Advocates say alligator farming has turned the demand for boots and bags into a boost for a species often seen as scary, bothersome or good only for their leathery skins
The U.S. economy, hobbled by last fall’s 43-day government shutdown, advanced at a sluggish 0.7% annual rate from October through December, the Commerce Department reported Friday in a big downgrade of its initial estimate
China has sharply reduced its warplane flights near Taiwan and analysts aren't sure why
South African soldiers deployed in the country’s high-crime areas have dismantled illegal mining operations Johannesburg
The Panama Canal's administrator says the war in the Middle East and higher fuel prices make the canal more appealing for shippers
Tom Dundon has sold a portion of the NHL's Carolina Hurricanes to three new minority owners
An artisanal mine collapse in the Central African Republic has killed eight miners and injures five others
The average long-term U.S. mortgage rate rose again this week, reflecting ongoing bond market jitters over the war with Iran
The biggest new restaurant trend is small
Some commercial ships near or in the Strait of Hormuz and in the Persian Gulf have declared themselves as China-linked since the Iran war began, marine traffic data show, as their operators try to reduce risks of being targeted in attacks
China is signaling it will stay focused on technology and economic growth, even as U.S. tensions with Iran rise